trodelvy - sacituzumab govitecan powder, for solution
(Sacituzumab Govitecan)Gilead Sciences, Inc.
Usage: Trodelvy treats adults with unresectable locally advanced or metastatic triple-negative breast cancer (2+ prior systemic therapies) or HR-positive, HER2-negative breast cancer (endocrine therapy plus 2+ additional metastatic systemic therapies).